Acrivon Therapeutics Inc (NASDAQ:ACRV)’s traded shares stood at 0.63 million during the last session, with the company’s beta value hitting 0.80. At the close of
In last trading session, Acrivon Therapeutics Inc (NASDAQ:ACRV) saw 0.35 million shares changing hands with its beta currently measuring 1.63. Company’s recent per share price
Acrivon Therapeutics Inc (NASDAQ:ACRV) has a beta value of 2.06 and has seen 14.21 million shares traded in the recent trading session. The company, currently
Acrivon Therapeutics Inc (NASDAQ:ACRV)’s traded shares stood at 0.13 million during the last session, with the company’s beta value hitting 1.87. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
